<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Reports (MDPI)</journal-id><journal-id journal-id-type="iso-abbrev">Reports (MDPI)</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Reports (MDPI)</journal-title></journal-title-group><issn pub-type="epub">2571-841X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10104440</article-id><article-id pub-id-type="pmcid-ver">PMC10104440.1</article-id><article-id pub-id-type="pmcaid">10104440</article-id><article-id pub-id-type="pmcaiid">10104440</article-id><article-id pub-id-type="manuscript-id">NIHMS1871544</article-id><article-id pub-id-type="pmid">37063094</article-id><article-id pub-id-type="doi">10.3390/reports5040041</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1871544</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1871544</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>COVID-19 Outcomes in a US Cohort of Persons Living with HIV (PLWH)</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9011-8456</contrib-id><name name-style="western"><surname>Spence</surname><given-names initials="AB">Amanda Blair</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Desale</surname><given-names initials="S">Sameer</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="J">Jennifer</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kumar</surname><given-names initials="P">Princy</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9108-5115</contrib-id><name name-style="western"><surname>Huang</surname><given-names initials="X">Xu</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3371-0845</contrib-id><name name-style="western"><surname>Cooper</surname><given-names initials="SE">Stanley Evan</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5112-1844</contrib-id><name name-style="western"><surname>Fernandez</surname><given-names initials="S">Stephen</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kassaye</surname><given-names initials="SG">Seble G.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Infectious Diseases, Georgetown University Medical Center, Washington, DC 20007, USA</aff><aff id="A2"><label>2</label>MedStar Health Research Institute, Hyattsville, MD 20782, USA</aff><aff id="A3"><label>3</label>Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1"><bold>Author Contributions:</bold> Conceptualization, A.B.S. and S.G.K.; formal analysis, S.D.; data curation, X.H., S.F., J.L. and S.E.C.; writing&#8212;original draft preparation, A.B.S.; writing&#8212;review and editing, S.G.K., P.K., J.L., S.E.C. and S.D. All authors have read and agreed to the published version of the manuscript.</p></fn><corresp id="CR1"><label>*</label>Correspondence: <email>abs132@georgetown.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>09</day><month>10</month><year>2022</year></pub-date><volume>5</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">433462</issue-id><elocation-id>41</elocation-id><pub-history><event event-type="nihms-submitted"><date><day>29</day><month>03</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>14</day><month>04</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>14</day><month>04</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 10:25:13.430"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><permissions><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1871544.pdf"/><abstract id="ABS1"><p id="P2">Reported coronavirus disease 2019 (COVID-19) outcomes in persons living with HIV (PLWH) vary across cohorts. We examined clinical characteristics and outcomes of PLWH with COVID-19 compared with a matched HIV-seronegative cohort in a mid-Atlantic US healthcare system. Multivariate logistic regression was used to explore factors associated with hospitalization and death/mechanical ventilation among PLWH. Among 281 PLWH with COVID-19, the mean age was 51.5 (SD 12.74) years, 63% were male, 86% were Black, and 87% had a HIV viral load &lt;200 copies/mL. Overall, 47% of PLWH versus 24% (<italic toggle="yes">p</italic> &lt; 0.001) of matched HIV-seronegative individuals were hospitalized. Rates of COVID-19 associated cardiovascular and thrombotic events, AKI, and infections were similar between PLWH and HIV-seronegative individuals. Overall mortality was 6% (<italic toggle="yes">n</italic> = 18/281) in PLWH versus 3% (<italic toggle="yes">n</italic> = 33/1124) HIV-seronegative, <italic toggle="yes">p</italic> &lt; 0.0001. Among admitted patients, mortality was 14% (<italic toggle="yes">n</italic> = 18/132) for PLWH and 13% (<italic toggle="yes">n</italic> = 33/269) for HIV-seronegative, <italic toggle="yes">p</italic> = 0.75. Among PLWH, hospitalization associated with older age aOR 1.04 (95% CI 1.01, 1.06), Medicaid insurance aOR 2.61 (95% CI 1.39, 4.97) and multimorbidity aOR 2.98 (95% CI 1.72, 5.23). Death/mechanical ventilation associated with older age aOR 1.06 (95% CI 1.01, 1.11), Medicaid insurance aOR 3.6 (95% CI 1.36, 9.74), and multimorbidity aOR 4.4 (95% CI 1.55, 15.9) in adjusted analyses. PLWH were hospitalized more frequently than the HIV-seronegative group and had a higher overall mortality rate, but once hospitalized had similar mortality rates. Older age, multimorbidity and insurance status associated with more severe outcomes among PLWH suggesting the importance of targeted interventions to mitigate the effects of modifiable inequities.</p></abstract><kwd-group><kwd>HIV</kwd><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>complications</kwd><kwd>outcomes</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="S1"><label>1.</label><title>Introduction</title><p id="P3">Data are mixed regarding the severity and clinical outcomes of coronavirus disease 2019 (COVID-19) among persons living with HIV (PLWH) and there are reports of both similar and worse clinical outcomes among different populations of PLWH co-infected with SARS-CoV-2. Early studies indicated a similar COVID-19 illness severity among PLWH and HIV-seronegative counterparts, but many of these reports were case series and/or had no matched controls [<xref rid="R1" ref-type="bibr">1</xref>&#8211;<xref rid="R11" ref-type="bibr">11</xref>]. There are also reports of higher rates of death and/or more severe disease among PLWH internationally and domestically [<xref rid="R11" ref-type="bibr">11</xref>&#8211;<xref rid="R15" ref-type="bibr">15</xref>]. Much of the literature describing COVID-19 in PLWH is limited to case series, single-center studies, includes mostly individuals on antiretroviral therapy (ART), and/or does not have matched control cohorts [<xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R16" ref-type="bibr">16</xref>]. However, even among population-based or registry studies, there is variability in reported outcomes, with some reporting increased mortality risk or hospitalizations and others not noting this association [<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R18" ref-type="bibr">18</xref>]. Thus, additional data across are needed to describe the impact of COVID-19 on PLWH.</p><p id="P4">There are consistent reports of higher disease severity or worse outcomes among PLWH with COVID-19 who have medical comorbidities such as diabetes, cardiovascular disease, obesity and/or chronic lung disease [<xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref>]. COVID-19-associated complications such as acute kidney injury (AKI), cardiac events/myocardial injury, thrombosis, and stroke are well reported in the literature, and risk factors for these events include pre-existing disease and/or other medical comorbidities [<xref rid="R21" ref-type="bibr">21</xref>&#8211;<xref rid="R33" ref-type="bibr">33</xref>]. However, the occurrence of these COVID-associated events have not yet been described in PLWH, a population with high prevalence of medical comorbidities including diabetes, obesity, hypertension, and dyslipidemia [<xref rid="R34" ref-type="bibr">34</xref>&#8211;<xref rid="R37" ref-type="bibr">37</xref>]. These COVID-19-associated events can account for significant morbidity, mortality, and healthcare expenditure among persons affected by COVID-19. Thus, an assessment of COVID-19 related outcomes and infection associated events is needed among PLWH.</p><p id="P5">We conducted a retrospective analysis of all PLWH diagnosed with COVID-19 seen in the MedStar Healthcare system. The MedStar Healthcare system is the largest healthcare provider in the Maryland and Washington, DC area that includes 10 hospitals and provides ambulatory care services in the hospitals and at free standing sites in the surrounding communities. These facilities serve urban, suburban, and rural populations [<xref rid="R38" ref-type="bibr">38</xref>]. The District of Columbia and Maryland have some of the highest rates of HIV in the country with 2360.8 and 652.9 diagnoses per 100,000, respectively [<xref rid="R39" ref-type="bibr">39</xref>]. Our sampling provides a representative sample of PLWH in the Mid-Atlantic region who sought clinical care. This allows for a detailed analysis of clinical characteristics of PLWH compared to a matched cohort as well as examination of COVID-19 associated events as we sought to characterize clinical characteristics of PLWH who were infected with COVID-19 as well as outcomes as compared to the HIV-seronegative.</p></sec><sec id="S2"><label>2.</label><title>Methods</title><sec id="S3"><title>Cohort Population and Data Sources:</title><p id="P6">All persons with a diagnosis of HIV, determined either via International Classification of Diseases (ICD-10) coding or laboratory testing with a diagnosis of COVID-19, who received care in the Medstar Healthcare system were included in this analysis. Individuals were considered to have a diagnosis of COVID-19 if an ICD-10 diagnosis code for COVID-19 or positive laboratory testing for SARS-CoV-2 by polymerase chain reaction (PCR) was documented between January 2020 and November 2020. In addition, an age- and sex/gender-frequency-matched control group of HIV-seronegative individuals with a diagnosis of COVID-19 was generated in a 1:4 ratio for comparison. There were no required standardized hospital protocols for hospital admission or COVID treatment and patient care decisions were based on the discretion of individual care providers.</p></sec><sec id="S4"><title>Variable Selection:</title><p id="P7">Demographic and clinical data were extracted from the Electronic Health Data Warehouse (MedStar Analytics Platform). Clinical data for this analysis included laboratory testing, medications/therapeutics, comorbid diagnoses as determined by ICD-10 coding, socio-demographics, oxygen requirements, and hospital length of stay. Individuals were considered to have multimorbidity (e.g., the co-occurrence of two or more chronic conditions) [<xref rid="R40" ref-type="bibr">40</xref>] if they had more than one of the following diagnoses: cardiovascular disease, obesity, diabetes, chronic renal disease, malignancy, or transplant. To determine accuracy of ICD-10 coding diagnoses, 25% of participants with each reported comorbid diagnosis were verified by manual chart review and the overall accuracy rate was 79% which is similar to other reports of discharge coding accuracy in the literature [<xref rid="R41" ref-type="bibr">41</xref>]. For those hospitalized, all laboratory data during the hospital admission were extracted. HIV viral load and CD4 + T lymphocyte count were obtained from the time most proximal to admission and/or COVID-19 diagnosis and viral loads were obtained until November 2020.</p></sec><sec id="S5"><title>Analytic Plan:</title><p id="P8">Descriptive statistics were used to describe cohort characteristics. Chi-square or Fisher&#8217;s exact tests were used for categorical variables and t-tests or Kruskal&#8211;Wallis tests were used for continuous variables to determine group differences [<xref rid="R42" ref-type="bibr">42</xref>] We examined differences in PLWH diagnosed with COVID-19 and PLWH without a diagnosis of COVID-19 as well as PLWH and HIV-seronegative individuals with a diagnosis of COVID-19. Univariate and multivariate logistic regression was used to explore factors associated with hospitalization and incident death/mechanical ventilation requirement among PLWH. Variables with a <italic toggle="yes">p</italic>-value &lt; 0.05 in the univariate analysis or selected based on known effect on SAR-CoV-2 outcomes were included in the multivariate analysis [<xref rid="R43" ref-type="bibr">43</xref>]. Data utilized for these analyses are included in the manuscript text and tables. All analyses were completed in R 4.0.0.</p></sec></sec><sec id="S6"><label>3.</label><title>Results</title><p id="P9">In total, 1632 PLWH were tested for SARS-CoV-2 infection among the 20,662 who received care within the MedStar healthcare system, <xref rid="F1" ref-type="fig">Figure 1</xref>. Characteristics of PLWH who tested for SARS-CoV-2 versus those who did not test for SARS-CoV-2 are outlined in <xref rid="SD1" ref-type="supplementary-material">Table S1</xref>. A total of 249 PLWH had a SARS-CoV-2 PCR confirmed infection, and an additional 32 had an ICD-10 coded COVID-19 diagnosis for a total of 281 PLWH with COVID-19.</p><p id="P10">The mean age of PLWH with COVID-19 was 51.5 (SD 12.7) years, 63% (<italic toggle="yes">n</italic> = 177) were male, and 86% (<italic toggle="yes">n</italic> = 237) were African American/Black. The median CD4 + T lymphocyte count was 623 cells/mm<sup>3</sup> [IQR 383, 938] and 87% had a HIV viral load &lt;200 copies/mL. Characteristics of tested PLWH with COVID-19 versus without COVID-19 are described in <xref rid="SD2" ref-type="supplementary-material">Table S2</xref>. Among those tested for SARS-CoV-2, PLWH who tested positive had lower rates of chronic renal disease (11% versus 12%, <italic toggle="yes">p</italic> = 0.030), higher rates of obesity (40% versus 33, <italic toggle="yes">p</italic> = 0.046), and higher median nadir CD4 + T lymphocyte counts (533 versus 413, <italic toggle="yes">p</italic> = 0.036). Among those tested, mean age in years, sex at birth, healthcare insurance status, CD4+ T lymphocyte count, and total number with HIV viral load &lt;200 copies/mL were similar between those with and without SARS-CoV-2 infection.</p><p id="P11">Incident inpatient and outpatient SARS-CoV-2 infections among PLWH and HIV-seronegative individuals are depicted in <xref rid="F2" ref-type="fig">Figure 2</xref>. Compared to age- and sex-matched HIV-negative individuals, more PLWH were hospitalized at 47% (<italic toggle="yes">n</italic> = 132) versus 24% (<italic toggle="yes">n</italic> = 269), <italic toggle="yes">p</italic> &lt; 0.001. Characteristics of PLWH and the matched cohort of HIV-seronegative individuals with COVID-19 are outlined in <xref rid="T1" ref-type="table">Table 1</xref>. The majority of PLWH, 86% (<italic toggle="yes">n</italic> = 237) were Black/African American versus 44% (<italic toggle="yes">n</italic> = 388) in the matched HIV-negative control group, <italic toggle="yes">p</italic> &lt; 0.001. There were more privately insured persons in the HIV-negative group at 75% (<italic toggle="yes">n</italic> = 818) versus 58% (<italic toggle="yes">n</italic> = 161), <italic toggle="yes">p</italic> &lt; 0001 among PLWH. Comorbid conditions were more common among PLWH including chronic liver disease at 24% (<italic toggle="yes">n</italic> = 70) versus 6% (<italic toggle="yes">n</italic> = 62), <italic toggle="yes">p</italic> &lt; 0.001; hypertension 59% (<italic toggle="yes">n</italic> = 165) versus 36% (<italic toggle="yes">n</italic> = 403), <italic toggle="yes">p</italic> &lt; 0.001; cardiovascular disease 62% (<italic toggle="yes">n</italic> = 174) versus 38% (<italic toggle="yes">n</italic> = 423), <italic toggle="yes">p</italic> &lt; 0.001; malignancy 10% (<italic toggle="yes">n</italic> = 28) versus 2% (<italic toggle="yes">n</italic> = 19), <italic toggle="yes">p</italic> &lt; 0.001; chronic lung disease 31% (<italic toggle="yes">n</italic> = 86) versus 12%(<italic toggle="yes">n</italic> = 134), <italic toggle="yes">p</italic> &lt; 0.001; chronic renal disease 25% (<italic toggle="yes">n</italic> = 69) and 10% (<italic toggle="yes">n</italic> = 117), <italic toggle="yes">p</italic> &lt; 0.001; and diabetes 33% (<italic toggle="yes">n</italic> = 92) versus 20% (<italic toggle="yes">n</italic> = 226), <italic toggle="yes">p</italic> &lt; 0.001. However, rates of post-COVID-19 cardiovascular, thrombotic, AKI, and infection events were similar between HIV-seropositive and HIV-seronegative groups overall as well among individuals who required hospitalization.</p><p id="P12">Among those hospitalized, the PLWH had higher prevalence of liver disease at 16% (<italic toggle="yes">n</italic> = 21) versus 4% (<italic toggle="yes">n</italic> = 10), <italic toggle="yes">p</italic> &lt; 0.001) and malignancy 19% (<italic toggle="yes">n</italic> = 25) versus 7% (<italic toggle="yes">n</italic> = 19), <italic toggle="yes">p</italic> = 0.001. The oxygen requirements and treatments were similar between the HIV-seropositive and HIV-seronegative groups. A total of 33% (<italic toggle="yes">n</italic> = 44) PLWH versus 31% (<italic toggle="yes">n</italic> = 83), <italic toggle="yes">p</italic> = 0.648, of HIV-seronegative individuals were admitted to the ICU. Among those admitted to the ICU, median length of stay was shorter among PLWH at 3 [IQR 1, 7.25] days versus 7 [IQR 3, 15] days. A total of 33% (<italic toggle="yes">n</italic> = 44) PLWH versus 31% (<italic toggle="yes">n</italic> = 83), <italic toggle="yes">p</italic> = 0.648, of HIV-seronegative individuals were admitted to the ICU. Inpatient mortality was similar for PLWH (<italic toggle="yes">n</italic> = 18/132) and HIV-seronegative individuals (<italic toggle="yes">n</italic> = 33/269) at 14% versus 13%, respectively, <italic toggle="yes">p</italic> = 0.750. The median length of hospital stay was 6 days [IQR 3, 11] for PLWH and 5.5 days [IQR 3, 11] for HIV-seronegative individuals, <italic toggle="yes">p</italic> = 0.889. Overall mortality was 6% (<italic toggle="yes">n</italic> = 18/281) in PLWH versus 3% (<italic toggle="yes">n</italic> = 33/1124) in HIV-seronegative individuals, <italic toggle="yes">p</italic> &lt; 0.0001.</p><p id="P13">In analyses adjusted for age, sex, insurance status and multimorbidity, hospitalization among PLWH associated with older age aOR 1.04 (95% CI 1.01, 1.06), Medicaid insurance aOR 2.61 (95% CI 1.39, 4.97) and multimorbidity aOR 2.98 (95% CI 1.72, 5.23) (<xref rid="T2" ref-type="table">Table 2</xref>). Death/mechanical ventilation requirement was associated with older age aOR 1.06 (95% CI 1.01, 1.11), Medicaid insurance aOR 3.6 (95% CI 1.36, 9.74), and multimorbidity aOR 4.4 (95% CI 1.55, 15.9) in analyses adjusted for age, sex, insurance status and multimorbidity (<xref rid="T3" ref-type="table">Table 3</xref>).</p></sec><sec id="S7"><label>4.</label><title>Discussion</title><p id="P14">In a clinical cohort of PLWH seeking healthcare in the mid-Atlantic US, 281 were diagnosed with COVID-19 between March 2020 and November 2020. Patients were seen in a variety of care settings including ambulatory and inpatient. This group was predominantly African American/Black, carried a heavy burden of prevalent medical comorbidities, and had mostly virologically well controlled HIV. PLWH were admitted to the inpatient setting more frequently than an age- and sex-matched cohort and had a higher overall mortality rate, but once admitted, had similar mortality to their HIV-seronegative counterparts. Despite more frequent hospital admissions, more comorbid illnesses, and higher overall mortality COVID-19 associated complications including AKI, thrombosis, cardiovascular events, and other infections were similar between PLWH and the matched HIV-seronegative control group. As in the general population, older age and multimorbidity are associated with more severe outcomes. Differences in outcomes were also noted by insurance status, some of which may be attributed to age but may also reflect social determinants of health. This study adds to the existing studies that suggest that older age, multiple medical comorbidities, and social determinants of health influence on COVID-19 outcomes.</p><p id="P15">COVID-19-associated complications such as cardiovascular events, AKI, and thrombotic events are frequently noted in the literature. AKI frequently complicates SARS-CoV-2 infection, and incidence rates are variable, but rates of up to 57% are reported among those hospitalized and/or admitted to an intensive care unit [<xref rid="R21" ref-type="bibr">21</xref>] AKI in the setting of COVID-19 is associated with Black/African American or Hispanic race, male sex, older age and other comorbidities such as diabetes, cardiovascular disease, hypertension, or baseline chronic kidney disease [<xref rid="R21" ref-type="bibr">21</xref>&#8211;<xref rid="R24" ref-type="bibr">24</xref>]. Further, myocardial injury is commonly reported among hospitalized patient with COVID-19, with risk factors being older age and a history of cardiovascular disease [<xref rid="R25" ref-type="bibr">25</xref>]. Thrombotic events are also common in persons with COVID-19 and pulmonary emboli and deep venous thrombosis have been reported in 20 to 30% of persons with COVID-19 with risk factors of older age and cardiovascular disease [<xref rid="R30" ref-type="bibr">30</xref>,<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R44" ref-type="bibr">44</xref>]. Persons with deep venous thrombosis and COVID-19 were older, had higher rates of cardiac injury, and oxygenation index [<xref rid="R45" ref-type="bibr">45</xref>]. HIV is a known risk factor for chronic kidney disease, cardiovascular disease, and venous thrombosis [<xref rid="R46" ref-type="bibr">46</xref>&#8211;<xref rid="R49" ref-type="bibr">49</xref>]. PLWH also have known higher rates of medical comorbidities, which was reflected in our cohort [<xref rid="R34" ref-type="bibr">34</xref>&#8211;<xref rid="R37" ref-type="bibr">37</xref>]. Thus, we initially hypothesized higher rates of COVID-19 associated complications. Studies are limited regarding COVID-19-associated complications among PLWH, but Durstenfeld et al. reported that hospitalized PLWH did not have elevated risk of major adverse cardiac events, mortality, or severity of disease.<sup><xref rid="R18" ref-type="bibr">18</xref></sup> Although the methodology was different, these findings, combined with our study findings of similar rates of COVID-19-related complications, suggest the need for additional study. Potential insights may be gained by further examining the immunologic response to disease among both PLWH as immune dysregulation is thought to contribute to SARS-CoV-2 pathogenesis including end organ disease such as myocardial injury, other cardiovascular dysfunction, or kidney dysfunction [<xref rid="R50" ref-type="bibr">50</xref>].</p><p id="P16">As other studies have reported, hospitalization rates were higher among PLWH in our cohort [<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R51" ref-type="bibr">51</xref>,<xref rid="R52" ref-type="bibr">52</xref>]. As more PLWH were admitted to the inpatient setting, overall mortality among all COVID-19 positive individuals, hospitalized and non-hospitalized was higher among PLWH versus the HIV-seronegative cohort. However, inpatient mortality was similar between PLWH and the HIV seronegative cohort. Differential hospitalization rates between the two groups may be reflective of differential admission practices and burden of comorbid disorders among PLWH. Our study corroborates the excess morbidity related to COVID-19 among PLWH found in other studies; however, our analysis may overestimate the mortality differences between PLWH and the HIV-seronegative group as we assume patients not admitted to our healthcare system survived infection and there may be unaccounted deaths in the outpatient group. Our study adds to the existing literature exploring the effect of COVID-19 on mortality among PLWH, yet additional work is needed to determine the effect of COVID-19 in PLWH as studies in various populations show differing outcomes [<xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R17" ref-type="bibr">17</xref>,<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R52" ref-type="bibr">52</xref>&#8211;<xref rid="R56" ref-type="bibr">56</xref>].</p><p id="P17">We determined risk factors related to hospitalization for SARS-CoV-2 or death/mechanical ventilation and found they were associated with age, insurance status, and multimorbidity. These findings are similar to those noted in the general HIV-seronegative population where known risk factors for hospitalization or severe disease include older age, or the presence of other comorbid disorders [<xref rid="R57" ref-type="bibr">57</xref>&#8211;<xref rid="R59" ref-type="bibr">59</xref>]. This is corroborated in other studies of PLWH with COVID-19 older PLWH or those with multiple comorbidities have more severe disease/worse outcomes [<xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R54" ref-type="bibr">54</xref>,<xref rid="R60" ref-type="bibr">60</xref>&#8211;<xref rid="R62" ref-type="bibr">62</xref>]. However, we did not observe more severe disease among ethnic/racial minorities as previously reported [<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R60" ref-type="bibr">60</xref>,<xref rid="R63" ref-type="bibr">63</xref>]. Our population was skewed with a majority of African American PLWH; thus, the assessment of the influence of race/ethnicity on COVID-19 severity is limited in our analysis. To our knowledge, the association of insurance type with hospitalization for COVID-19 or death/mechanical ventilation among PLWH has not been reported in the literature. However, those that are uninsured/self-pay and Medicaid recipients are socially and economically vulnerable populations [<xref rid="R64" ref-type="bibr">64</xref>,<xref rid="R65" ref-type="bibr">65</xref>], and the higher rates of severe COVID-19 disease may be reflective of differences in health seeking behavior, health service delivery, or other social determinants of health that are confounders in the relationship. The association of social determinants of health and COVID-19 outcomes has been described in the literature and access and delivery of care may be targets for intervention [<xref rid="R66" ref-type="bibr">66</xref>,<xref rid="R67" ref-type="bibr">67</xref>].</p></sec><sec id="S8"><label>5.</label><title>Limitations</title><p id="P18">Our study utilized the data available in the Medstar Health electronic medical registry, so we are unable to account for care sought outside this healthcare system, HIV treatment history, or duration of HIV infection. Additionally, all comorbid diagnoses were determined by ICD-10 codes. These codes were developed for administrative use and have their own inherent bias, but they are used by public health organizations to conduct surveillance and have also successfully been used by researchers including in large studies of COVID-19 [<xref rid="R52" ref-type="bibr">52</xref>,<xref rid="R68" ref-type="bibr">68</xref>&#8211;<xref rid="R70" ref-type="bibr">70</xref>]. To ensure the data accuracy we conducted manual abstraction of a subset of the population and the data accuracy was consistent with that of the published literature [<xref rid="R41" ref-type="bibr">41</xref>]. The majority of the participants in this study were virologically suppressed and sought healthcare. Thus, our findings may not be representative of persons with advanced HIV or not receiving care. Additionally, the therapeutic approaches to treatment and prevention of COVID-19 changed over the duration of the study which likely impacted outcomes and ability to compare our results with that of studies performed early in the pandemic. We utilized electronic health records that do not capture genomic surveillance data, but the data analyzed for this study included individuals diagnosed with COVID-19 between March 2020 and November 2020. The alpha (B.1.1.7.) variant was first reported in the United Kingdom in December of 2020. Thus, individuals in our cohort likely were likely infected with the original COVID-19 strain. The emergence of the alpha, delta, and omicron variants likely affected disease severity and outcomes and our findings may not be generalizable to those infected with other variants. Our cohort was predominantly African American/Black, and although representative of the HIV-epidemic in the area, this may have affected our outcomes as other studies have noted differences in outcomes by race. Other studies noted differences by race and COVID-19 outcomes, our population was predominantly African American and this may have influenced outcomes [<xref rid="R71" ref-type="bibr">71</xref>&#8211;<xref rid="R73" ref-type="bibr">73</xref>]. We were not able to fully assess difference by race given the unequal racial population distribution Additional studies are needed to identify emerging trends in hospitalizations, morbidity, and mortality among PLWH with more recent SARS-CoV-2 variants, and contemporary SARS-CoV-2 prevention and treatment modalities.</p></sec><sec id="S9"><label>6.</label><title>Conclusions</title><p id="P19">Our findings suggest disparities in COVID-19 morbidity among PLWH in the form of excess hospitalizations and higher mortality when including both inpatients and outpatient COVID-19 diagnoses. Despite higher burdens of baseline comorbid illness, PLWH did not experience more cardiovascular, acute kidney injury, or thrombotic events. Similar to other studies, older age, multimorbidity, and Medicaid insurance were associated with more severe outcomes among PLWH. Ongoing assessments of these findings and COVID-19 prevention efforts are needed among PLWH, especially socially or economically vulnerable populations, those with advanced age, or multiple comorbidities.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data" orientation="portrait"><label>Supplemental Tables 1</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS1871544-supplement-Supplemental_Tables_1.pdf" id="d64e650" position="anchor" orientation="portrait"/></supplementary-material><supplementary-material id="SD2" position="float" content-type="local-data" orientation="portrait"><label>Supplemental Tables 2</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS1871544-supplement-Supplemental_Tables_2.pdf" id="d64e653" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><ack id="S10"><title>Funding:</title><p id="P20">This research has been supported by the services and resources provided by the District of Columbia Center for AIDS Research, a National Institutes of Health funded program (P30 AI117970). S.E.C is supported under T32 AI007613 by the National Institute of Allergy and Infectious Diseases.</p><sec sec-type="COI-statement" id="S11"><title>Conflicts of Interest:</title><p id="P21">P.K. reports research grants from Eli Lilly, G.S.K., Merck, Gilead, Regeneron, and American Gene Technologies and financial interest in Merck, Johnson &amp; Johnson, G.S.K., Gilead, and Pfizer.</p></sec><sec id="S12"><title>Institutional Review Board Statement:</title><p id="P22">This study was approved by the Georgetown University Intuitional Review Board (STUDY00001455).</p></sec></ack><fn-group><fn id="FN2"><p id="P24"><bold>Informed Consent Statement:</bold> Not Applicable.</p></fn><fn id="FN3"><p id="P25"><bold>Supplementary Materials:</bold> The following are available online at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10.3390/reports5040041/s1" ext-link-type="doi">https://www.mdpi.com/article/10.3390/reports5040041/s1</ext-link>, <xref rid="SD1" ref-type="supplementary-material">Table S1</xref>: Characteristics of PLWH and SARS-CoV-2 testing status; <xref rid="SD2" ref-type="supplementary-material">Table S2</xref>: Characteristics of persons living with HIV who completed SARS-CoV-2 testing with and without infection.</p></fn></fn-group><sec sec-type="data-availability" id="S13"><title>Data Availability Statement:</title><p id="P23">Data is contained within the article and Supplement Material.</p></sec><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Inciarte</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Gonzalez-Cordon</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Rojas</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Torres</surname><given-names>B</given-names></name>; <name name-style="western"><surname>de Lazzari</surname><given-names>E</given-names></name>; <name name-style="western"><surname>de la Mora</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Martinez-Rebollar</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Laguno</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Callau</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Gonzalez-Navarro</surname><given-names>A</given-names></name>; <etal/><article-title>Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: A single-center, prospective observational study</article-title>. <source>AIDS</source><year>2020</year>, <volume>34</volume>, <fpage>1775</fpage>&#8211;<lpage>1780</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32773471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000002643</pub-id><pub-id pub-id-type="pmcid">PMC7493771</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Xie</surname><given-names>N</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>X</given-names></name>; <name name-style="western"><surname>Yan</surname><given-names>H</given-names></name>; <name name-style="western"><surname>Ding</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>H</given-names></name>; <name name-style="western"><surname>Ruan</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>G</given-names></name>; <name name-style="western"><surname>He</surname><given-names>N</given-names></name>; <etal/><article-title>Epidemiological, Virological and Serological Features of Coronavirus Disease 2019 (COVID-19) Cases in People Living with Human Immunodeficiency Virus in Wuhan: A Population-based Cohort Study</article-title>. <source>Clin. Infect. Dis</source><year>2020</year>, <volume>73</volume>, <fpage>e2086</fpage>&#8211;<lpage>e2094</lpage>. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa1186</pub-id><pub-id pub-id-type="pmcid">PMC7454403</pub-id><pub-id pub-id-type="pmid">32803216</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Gervasoni</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Meraviglia</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Riva</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Giacomelli</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Oreni</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Minisci</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Atzori</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Ridolfo</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Cattaneo</surname><given-names>D</given-names></name><article-title>Clinical features and outcomes of HIV patients with coronavirus disease 2019</article-title>. <source>Clin. Infect. Dis</source><year>2020</year>, <volume>71</volume>, <fpage>2276</fpage>&#8211;<lpage>2278</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32407467</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa579</pub-id><pub-id pub-id-type="pmcid">PMC7239244</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Byrd</surname><given-names>KM</given-names></name>; <name name-style="western"><surname>Beckwith</surname><given-names>CG</given-names></name>; <name name-style="western"><surname>Garland</surname><given-names>JM</given-names></name>; <name name-style="western"><surname>Johnson</surname><given-names>JE</given-names></name>; <name name-style="western"><surname>Aung</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Cu-Uvin</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Farmakiotis</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Flanigan</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Gillani</surname><given-names>FS</given-names></name>; <name name-style="western"><surname>Macias-Gil</surname><given-names>R</given-names></name>; <etal/><article-title>SARS-CoV-2 and HIV coinfection: Clinical experience from Rhode Island, United States</article-title>. <source>J. Int. AIDS Soc</source><year>2020</year>, <volume>23</volume>, e25573. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jia2.25573</pub-id><pub-id pub-id-type="pmcid">PMC7357287</pub-id><pub-id pub-id-type="pmid">32657527</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Calza</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Bon</surname><given-names>I</given-names></name>; <name name-style="western"><surname>Tadolini</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Borderi</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Colangeli</surname><given-names>V</given-names></name>; <name name-style="western"><surname>Badia</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Verucchi</surname><given-names>G</given-names></name>; <name name-style="western"><surname>Rossini</surname><given-names>G</given-names></name>; <name name-style="western"><surname>Vocale</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Gaibani</surname><given-names>P</given-names></name>; <etal/><article-title>COVID-19 in patients with HIV-1 infection: A single-centre experience in northern Italy</article-title>. <source>Infection</source><year>2021</year>, <volume>49</volume>, <fpage>333</fpage>&#8211;<lpage>337</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32748333</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s15010-020-01492-7</pub-id><pub-id pub-id-type="pmcid">PMC7397968</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Okoh</surname><given-names>AK</given-names></name>; <name name-style="western"><surname>Bishburg</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Grinberg</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Nagarakanti</surname><given-names>S</given-names></name><article-title>COVID-19 pneumonia in patients with HIV&#8212;A Case Series</article-title>. <source>J. Acquir. Immune Defic. Syndr</source><year>2020</year>, <volume>85</volume>, <fpage>e4</fpage>&#8211;<lpage>e5</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32483000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAI.0000000000002411</pub-id><pub-id pub-id-type="pmcid">PMC7302088</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shalev</surname><given-names>N</given-names></name>; <name name-style="western"><surname>Scherer</surname><given-names>M</given-names></name>; <name name-style="western"><surname>LaSota</surname><given-names>ED</given-names></name>; <name name-style="western"><surname>Antoniou</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Yin</surname><given-names>MT</given-names></name>; <name name-style="western"><surname>Zucker</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Sobieszczyk</surname><given-names>ME</given-names></name><article-title>Clinical Characteristics and Outcomes in People Living with Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019</article-title>. <source>Clin. Infect. Dis</source><year>2020</year>, <volume>71</volume>, <fpage>2294</fpage>&#8211;<lpage>2297</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">32472138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa635</pub-id><pub-id pub-id-type="pmcid">PMC7314170</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Sigel</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Swartz</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Golden</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Paranjpe</surname><given-names>I</given-names></name>; <name name-style="western"><surname>Somani</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Richter</surname><given-names>F</given-names></name>; <name name-style="western"><surname>De Freitas</surname><given-names>JK</given-names></name>; <name name-style="western"><surname>Miotto</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Polak</surname><given-names>P</given-names></name>; <etal/><article-title>Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients in New York City</article-title>. <source>Clin. Infect. Dis</source><year>2020</year>, <volume>71</volume>, <fpage>2933</fpage>&#8211;<lpage>2938</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32594164</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa880</pub-id><pub-id pub-id-type="pmcid">PMC7337691</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Collins</surname><given-names>LF</given-names></name>; <name name-style="western"><surname>Moran</surname><given-names>CA</given-names></name>; <name name-style="western"><surname>Oliver</surname><given-names>NT</given-names></name>; <name name-style="western"><surname>Moanna</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Lahiri</surname><given-names>CD</given-names></name>; <name name-style="western"><surname>Colasanti</surname><given-names>JA</given-names></name>; <name name-style="western"><surname>Kelley</surname><given-names>CF</given-names></name>; <name name-style="western"><surname>Nguyen</surname><given-names>ML</given-names></name>; <name name-style="western"><surname>Marconi</surname><given-names>VC</given-names></name>; <name name-style="western"><surname>Armstrong</surname><given-names>WS</given-names></name>; <etal/><article-title>Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, Georgia</article-title>. <source>AIDS</source><year>2020</year>, <volume>34</volume>, <fpage>1789</fpage>&#8211;<lpage>1794</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32675581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000002632</pub-id><pub-id pub-id-type="pmcid">PMC7484356</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ridgway</surname><given-names>JP</given-names></name>; <name name-style="western"><surname>Farley</surname><given-names>B</given-names></name>; <name name-style="western"><surname>Benoit</surname><given-names>J-L</given-names></name>; <name name-style="western"><surname>Frohne</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Hazra</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Pettit</surname><given-names>N</given-names></name>; <name name-style="western"><surname>Pho</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Pursell</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Saltzman</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Schmitt</surname><given-names>J</given-names></name>; <etal/><article-title>A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois</article-title>. <source>AIDS Patient Care STDS</source><year>2020</year>, <volume>34</volume>, <fpage>331</fpage>&#8211;<lpage>335</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">32469614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/apc.2020.0103</pub-id><pub-id pub-id-type="pmcid">PMC7415217</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name>; <name name-style="western"><surname>Ming</surname><given-names>F</given-names></name>; <name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name>; <name name-style="western"><surname>Mo</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Gao</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>W</given-names></name>; <name name-style="western"><surname>Liang</surname><given-names>K</given-names></name><article-title>Patterns of HIV and SARS-CoV-2 co-infection in Wuhan, China</article-title>. <source>J. Int. AIDS Soc</source><year>2020</year>, <volume>23</volume>, e25568. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jia2.25568</pub-id><pub-id pub-id-type="pmcid">PMC7323012</pub-id><pub-id pub-id-type="pmid">32697865</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Boulle</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Davies</surname><given-names>M-A</given-names></name>; <name name-style="western"><surname>Hussey</surname><given-names>H</given-names></name>; <name name-style="western"><surname>Ismail</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Morden</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Vundle</surname><given-names>Z</given-names></name>; <name name-style="western"><surname>Zweigenthal</surname><given-names>V</given-names></name>; <name name-style="western"><surname>Mahomed</surname><given-names>H</given-names></name>; <name name-style="western"><surname>Paleker</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Pienaar</surname><given-names>D</given-names></name>; <etal/><article-title>Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa</article-title>. <source>Clin. Infect. Dis</source><year>2020</year>, <volume>73</volume>, <fpage>e2005</fpage>&#8211;<lpage>e2015</lpage>. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa1198</pub-id><pub-id pub-id-type="pmcid">PMC7499501</pub-id><pub-id pub-id-type="pmid">32860699</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Miyashita</surname><given-names>H</given-names></name>; <name name-style="western"><surname>Kuno</surname><given-names>T</given-names></name><article-title>Prognosis of coronavirus disease 2019 (COVID-19) in patients with HIV infection in New York City</article-title>. <source>HIV Med</source>. <year>2021</year>, <volume>22</volume>, <fpage>e1</fpage>&#8211;<lpage>e2</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32829525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/hiv.12920</pub-id><pub-id pub-id-type="pmcid">PMC7461410</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Tesoriero</surname><given-names>JM</given-names></name>; <name name-style="western"><surname>Swain</surname><given-names>C-AE</given-names></name>; <name name-style="western"><surname>Pierce</surname><given-names>JL</given-names></name>; <name name-style="western"><surname>Zamboni</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Holtgrave</surname><given-names>DR</given-names></name>; <name name-style="western"><surname>Gonzalez</surname><given-names>CJ</given-names></name>; <name name-style="western"><surname>Udo</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Morne</surname><given-names>JE</given-names></name>; <name name-style="western"><surname>Hart-Malloy</surname><given-names>R</given-names></name>; <etal/><article-title>COVID-19 Outcomes Among Persons Living with or without Diagnosed HIV Infection in New York State</article-title>. <source>JAMA Netw. Open</source><year>2021</year>, <volume>4</volume>, e2037069. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2020.37069</pub-id><pub-id pub-id-type="pmcid">PMC7859843</pub-id><pub-id pub-id-type="pmid">33533933</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Geretti</surname><given-names>AM</given-names></name>; <name name-style="western"><surname>Stockdale</surname><given-names>AJ</given-names></name>; <name name-style="western"><surname>Kelly</surname><given-names>SH</given-names></name>; <name name-style="western"><surname>Cevik</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Collins</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Waters</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Villa</surname><given-names>G</given-names></name>; <name name-style="western"><surname>Docherty</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Harrison</surname><given-names>EM</given-names></name>; <name name-style="western"><surname>Turtle</surname><given-names>L</given-names></name>; <etal/><article-title>Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization among People with Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study</article-title>. <source>Clin. Infect. Dis</source><year>2021</year>, <volume>73</volume>, <fpage>e2095</fpage>&#8211;<lpage>e2106</lpage>. [CrossRef]<pub-id pub-id-type="pmid">33095853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa1605</pub-id><pub-id pub-id-type="pmcid">PMC7665382</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Vizcarra</surname><given-names>P</given-names></name>; <name name-style="western"><surname>P&#233;rez-El&#237;as</surname><given-names>MJ</given-names></name>; <name name-style="western"><surname>Quereda</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Moreno</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Vivancos</surname><given-names>MJ</given-names></name>; <name name-style="western"><surname>Dronda</surname><given-names>F</given-names></name>; <name name-style="western"><surname>Casado</surname><given-names>JL</given-names></name>; <article-title>COVID-19 ID Team. Description of COVID-19 in HIV-infected individuals: A single-centre, prospective cohort</article-title>. <source>Lancet HIV</source><year>2020</year>, <volume>7</volume>, <fpage>e554</fpage>&#8211;<lpage>e564</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32473657</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2352-3018(20)30164-8</pub-id><pub-id pub-id-type="pmcid">PMC7255735</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Durstenfeld</surname><given-names>MS</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name>; <name name-style="western"><surname>Rodriguez</surname><given-names>F</given-names></name>; <name name-style="western"><surname>Secemsky</surname><given-names>EA</given-names></name>; <name name-style="western"><surname>Parikh</surname><given-names>RV</given-names></name>; <name name-style="western"><surname>Hsue</surname><given-names>PY</given-names></name><article-title>Association of HIV infection with outcomes among adults hospitalized with COVID-19</article-title>. <source>AIDS</source><year>2022</year>, <volume>36</volume>, <fpage>391</fpage>&#8211;<lpage>398</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">34750295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000003129</pub-id><pub-id pub-id-type="pmcid">PMC8795492</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bhaskaran</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Rentsch</surname><given-names>CT</given-names></name>; <name name-style="western"><surname>MacKenna</surname><given-names>B</given-names></name>; <name name-style="western"><surname>Schultze</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Mehrkar</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Bates</surname><given-names>CJ</given-names></name>; <name name-style="western"><surname>Eggo</surname><given-names>RM</given-names></name>; <name name-style="western"><surname>Morton</surname><given-names>CE</given-names></name>; <name name-style="western"><surname>Bacon</surname><given-names>SCJ</given-names></name>; <name name-style="western"><surname>Inglesby</surname><given-names>P</given-names></name>; <etal/><article-title>HIV infection and COVID-19 death: A population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform</article-title>. <source>Lancet HIV</source><year>2021</year>, <volume>8</volume>, <fpage>e24</fpage>&#8211;<lpage>e32</lpage>. [CrossRef]<pub-id pub-id-type="pmid">33316211</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2352-3018(20)30305-2</pub-id><pub-id pub-id-type="pmcid">PMC7773630</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dandachi</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Geiger</surname><given-names>G</given-names></name>; <name name-style="western"><surname>Montgomery</surname><given-names>MW</given-names></name>; <name name-style="western"><surname>Karmen-Tuohy</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Golzy</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Antar</surname><given-names>AAR</given-names></name>; <name name-style="western"><surname>Llibre</surname><given-names>JM</given-names></name>; <name name-style="western"><surname>Camazine</surname><given-names>M</given-names></name>; <name name-style="western"><surname>D&#237;az-De Santiago</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Carlucci</surname><given-names>PM</given-names></name>; <etal/><article-title>Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19</article-title>. <source>Clin. Infect. Dis</source><year>2021</year>, <volume>73</volume>, <fpage>e1964</fpage>&#8211;<lpage>e1972</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">32905581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa1339</pub-id><pub-id pub-id-type="pmcid">PMC7499544</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ambrosioni</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Blanco</surname><given-names>JL</given-names></name>; <name name-style="western"><surname>Reyes-Urue&#241;a</surname><given-names>JM</given-names></name>; <name name-style="western"><surname>Davies</surname><given-names>M-A</given-names></name>; <name name-style="western"><surname>Sued</surname><given-names>O</given-names></name>; <name name-style="western"><surname>Marcos</surname><given-names>MA</given-names></name>; <name name-style="western"><surname>Mart&#237;nez</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Bertagnolio</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Alcam&#237;</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Miro</surname><given-names>JM</given-names></name>; <etal/><article-title>Overview of SARS-CoV-2 infection in adults living with HIV</article-title>. <source>Lancet HIV</source><year>2021</year>, <volume>8</volume>, <fpage>e294</fpage>&#8211;<lpage>e305</lpage>. [CrossRef]<pub-id pub-id-type="pmid">33915101</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2352-3018(21)00070-9</pub-id><pub-id pub-id-type="pmcid">PMC8075775</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nugent</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Aklilu</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Yamamoto</surname><given-names>Y</given-names></name>; <name name-style="western"><surname>Simonov</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>F</given-names></name>; <name name-style="western"><surname>Biswas</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Ghazi</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Greenberg</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Mansour</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Moledina</surname><given-names>D</given-names></name>; <etal/><article-title>Assessment of Acute Kidney Injury and Longitudinal Kidney Function after Hospital Discharge Among Patients with and without COVID-19</article-title>. <source>JAMA Netw. Open</source><year>2021</year>, <volume>4</volume>, e211095. [CrossRef] [PubMed]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2021.1095</pub-id><pub-id pub-id-type="pmcid">PMC7948062</pub-id><pub-id pub-id-type="pmid">33688965</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fisher</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Neugarten</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Bellin</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Yunes</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Stahl</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Johns</surname><given-names>TS</given-names></name>; <name name-style="western"><surname>Abramowitz</surname><given-names>MK</given-names></name>; <name name-style="western"><surname>Levy</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Kumar</surname><given-names>N</given-names></name>; <name name-style="western"><surname>Mokrzycki</surname><given-names>MH</given-names></name>; <etal/><article-title>AKI in Hospitalized Patients with and without COVID-19: A Comparison Study</article-title>. <source>J. Am. Soc. Nephrol</source><year>2020</year>, <volume>31</volume>, <fpage>2145</fpage>&#8211;<lpage>2157</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">32669322</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1681/ASN.2020040509</pub-id><pub-id pub-id-type="pmcid">PMC7461660</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hirsch</surname><given-names>JS</given-names></name>; <name name-style="western"><surname>Ng</surname><given-names>JH</given-names></name>; <name name-style="western"><surname>Ross</surname><given-names>DW</given-names></name>; <name name-style="western"><surname>Sharma</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Shah</surname><given-names>HH</given-names></name>; <name name-style="western"><surname>Barnett</surname><given-names>RL</given-names></name>; <name name-style="western"><surname>Hazzan</surname><given-names>AD</given-names></name>; <name name-style="western"><surname>Fishbane</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Jhaveri</surname><given-names>KD</given-names></name>; <collab>Northwell COVID-19 Research Consortium</collab>; <etal/><article-title>Acute kidney injury in patients hospitalized with COVID-19</article-title>. <source>Kidney Int</source>. <year>2020</year>, <volume>98</volume>, <fpage>209</fpage>&#8211;<lpage>218</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">32416116</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.kint.2020.05.006</pub-id><pub-id pub-id-type="pmcid">PMC7229463</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Chan</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Chaudhary</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Saha</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Chauhan</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Vaid</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Paranjpe</surname><given-names>I</given-names></name>; <name name-style="western"><surname>Somani</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Richter</surname><given-names>F</given-names></name>; <name name-style="western"><surname>Miotto</surname><given-names>R</given-names></name>; <etal/><article-title>AKI in Hospitalized Patients with COVID-19</article-title>. <source>J. Am. Soc. Nephrol</source><year>2021</year>, <volume>32</volume>, <fpage>151</fpage>&#8211;<lpage>160</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32883700</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1681/ASN.2020050615</pub-id><pub-id pub-id-type="pmcid">PMC7894657</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Lala</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Johnson</surname><given-names>KW</given-names></name>; <name name-style="western"><surname>Januzzi</surname><given-names>JL</given-names></name>; <name name-style="western"><surname>Russak</surname><given-names>AJ</given-names></name>; <name name-style="western"><surname>Paranjpe</surname><given-names>I</given-names></name>; <name name-style="western"><surname>Richter</surname><given-names>F</given-names></name>; <name name-style="western"><surname>Zhao</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Somani</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Van Vleck</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Vaid</surname><given-names>A</given-names></name>; <etal/><article-title>Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection</article-title>. <source>J. Am. Coll. Cardiol</source><year>2020</year>, <volume>76</volume>, <fpage>533</fpage>&#8211;<lpage>546</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32517963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacc.2020.06.007</pub-id><pub-id pub-id-type="pmcid">PMC7279721</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Kotecha</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Knight</surname><given-names>DS</given-names></name>; <name name-style="western"><surname>Razvi</surname><given-names>Y</given-names></name>; <name name-style="western"><surname>Kumar</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Vimalesvaran</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Thornton</surname><given-names>G</given-names></name>; <name name-style="western"><surname>Patel</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Chacko</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Brown</surname><given-names>JT</given-names></name>; <name name-style="western"><surname>Coyle</surname><given-names>C</given-names></name>; <etal/><article-title>Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance</article-title>. <source>Eur. Heart J</source><year>2021</year>, <volume>42</volume>, <fpage>1866</fpage>&#8211;<lpage>1878</lpage>. [CrossRef]<pub-id pub-id-type="pmid">33596594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehab075</pub-id><pub-id pub-id-type="pmcid">PMC7928984</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Zhao</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Tang</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Han</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Zhan</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>W</given-names></name>; <name name-style="western"><surname>Zeng</surname><given-names>H</given-names></name>; <name name-style="western"><surname>Tao</surname><given-names>Q</given-names></name>; <name name-style="western"><surname>Xia</surname><given-names>L</given-names></name><article-title>Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging</article-title>. <source>JACC Cardiovasc. Imaging</source><year>2020</year>, <volume>13</volume>, <fpage>2330</fpage>&#8211;<lpage>2339</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32763118</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcmg.2020.05.004</pub-id><pub-id pub-id-type="pmcid">PMC7214335</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ojha</surname><given-names>V</given-names></name>; <name name-style="western"><surname>Verma</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Pandey</surname><given-names>NN</given-names></name>; <name name-style="western"><surname>Mani</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Malhi</surname><given-names>AS</given-names></name>; <name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Jagia</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Roy</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Sharma</surname><given-names>S</given-names></name><article-title>Cardiac Magnetic Resonance Imaging in Coronavirus Disease 2019 (COVID-19): A Systematic Review of Cardiac Magnetic Resonance Imaging Findings in 199 Patients</article-title>. <source>J. Thorac. Imaging</source><year>2021</year>, <volume>36</volume>, <fpage>73</fpage>&#8211;<lpage>83</lpage>. [CrossRef]<pub-id pub-id-type="pmid">33306666</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/RTI.0000000000000574</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Puntmann</surname><given-names>VO</given-names></name>; <name name-style="western"><surname>Carerj</surname><given-names>ML</given-names></name>; <name name-style="western"><surname>Wieters</surname><given-names>I</given-names></name>; <name name-style="western"><surname>Fahim</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Arendt</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Hoffmann</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Shchendrygina</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Escher</surname><given-names>F</given-names></name>; <name name-style="western"><surname>Vasa-Nicotera</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Zeiher</surname><given-names>AM</given-names></name>; <etal/><article-title>Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered from Coronavirus Disease 2019 (COVID-19)</article-title>. <source>JAMA Cardiol</source>. <year>2020</year>, <volume>5</volume>, <fpage>1265</fpage>&#8211;<lpage>1273</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32730619</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamacardio.2020.3557</pub-id><pub-id pub-id-type="pmcid">PMC7385689</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hanff</surname><given-names>TC</given-names></name>; <name name-style="western"><surname>Mohareb</surname><given-names>AM</given-names></name>; <name name-style="western"><surname>Giri</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Cohen</surname><given-names>JB</given-names></name>; <name name-style="western"><surname>Chirinos</surname><given-names>JA</given-names></name><article-title>Thrombosis in COVID-19</article-title>. <source>Am. J. Hematol</source><year>2020</year>, <volume>95</volume>, <fpage>1578</fpage>&#8211;<lpage>1589</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32857878</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ajh.25982</pub-id><pub-id pub-id-type="pmcid">PMC7674272</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Malas</surname><given-names>MB</given-names></name>; <name name-style="western"><surname>Naazie</surname><given-names>IN</given-names></name>; <name name-style="western"><surname>Elsayed</surname><given-names>N</given-names></name>; <name name-style="western"><surname>Mathlouthi</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Marmor</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Clary</surname><given-names>B</given-names></name><article-title>Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis</article-title>. <source>EClinicalMedicine</source><year>2020</year>, <volume>29</volume>, 100639. [CrossRef] [PubMed]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eclinm.2020.100639</pub-id><pub-id pub-id-type="pmcid">PMC7679115</pub-id><pub-id pub-id-type="pmid">33251499</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Qureshi</surname><given-names>AI</given-names></name>; <name name-style="western"><surname>Baskett</surname><given-names>WI</given-names></name>; <name name-style="western"><surname>Huang</surname><given-names>W</given-names></name>; <name name-style="western"><surname>Shyu</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Myers</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Raju</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Lobanova</surname><given-names>I</given-names></name>; <name name-style="western"><surname>Suri</surname><given-names>MFK</given-names></name>; <name name-style="western"><surname>Naqvi</surname><given-names>SH</given-names></name>; <name name-style="western"><surname>French</surname><given-names>BR</given-names></name>; <etal/><article-title>Acute Ischemic Stroke and COVID-19: An Analysis of 27 676 Patients</article-title>. <source>Stroke</source><year>2021</year>, <volume>52</volume>, <fpage>905</fpage>&#8211;<lpage>912</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">33535779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.120.031786</pub-id><pub-id pub-id-type="pmcid">PMC7903982</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Merkler</surname><given-names>AE</given-names></name>; <name name-style="western"><surname>Parikh</surname><given-names>NS</given-names></name>; <name name-style="western"><surname>Mir</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Gupta</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Kamel</surname><given-names>H</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Lantos</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Schenck</surname><given-names>EJ</given-names></name>; <name name-style="western"><surname>Goyal</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Bruce</surname><given-names>SS</given-names></name>; <etal/><article-title>Risk of Ischemic Stroke in Patients with Coronavirus Disease 2019 (COVID-19) vs Patients with Influenza</article-title>. <source>JAMA Neurol</source>. <year>2020</year>, <volume>77</volume>, <fpage>1366</fpage>. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2020.2730</pub-id><pub-id pub-id-type="pmcid">PMC7333175</pub-id><pub-id pub-id-type="pmid">32614385</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Palella</surname><given-names>FJ</given-names></name>; <name name-style="western"><surname>Hart</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Armon</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Tedaldi</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Yangco</surname><given-names>B</given-names></name>; <name name-style="western"><surname>Novak</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Battalora</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Ward</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Buchacz</surname><given-names>K</given-names></name>; <etal/><article-title>Non-AIDS comorbidity burden differs by sex, race, and insurance type in aging adults in HIV care</article-title>. <source>AIDS</source><year>2019</year>, <volume>33</volume>, <fpage>2327</fpage>&#8211;<lpage>2335</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">31764098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000002349</pub-id></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Collins</surname><given-names>LF</given-names></name>; <name name-style="western"><surname>Sheth</surname><given-names>AN</given-names></name>; <name name-style="western"><surname>Mehta</surname><given-names>CC</given-names></name>; <name name-style="western"><surname>Naggie</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Golub</surname><given-names>ET</given-names></name>; <name name-style="western"><surname>Anastos</surname><given-names>K</given-names></name>; <name name-style="western"><surname>French</surname><given-names>AL</given-names></name>; <name name-style="western"><surname>Kassaye</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Taylor</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Fischl</surname><given-names>MA</given-names></name>; <etal/><article-title>The Prevalence and Burden of Non-AIDS Comorbidities Among Women Living with or at Risk for Human Immunodeficiency Virus Infection in the United States</article-title>. <source>Clin. Infect. Dis</source><year>2021</year>, <volume>72</volume>, <fpage>1301</fpage>&#8211;<lpage>1311</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32115628</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa204</pub-id><pub-id pub-id-type="pmcid">PMC8075036</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schouten</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Wit</surname><given-names>FW</given-names></name>; <name name-style="western"><surname>Stolte</surname><given-names>IG</given-names></name>; <name name-style="western"><surname>Kootstra</surname><given-names>NA</given-names></name>; <name name-style="western"><surname>van der Valk</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Geerlings</surname><given-names>SE</given-names></name>; <name name-style="western"><surname>Prins</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Reiss</surname><given-names>P</given-names></name>; <collab>AGEhIV Cohort Study Group</collab>. <article-title>Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: The AGEhIV cohort study</article-title>. <source>Clin. Infect. Dis</source><year>2014</year>, <volume>59</volume>, <fpage>1787</fpage>&#8211;<lpage>1797</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">25182245</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciu701</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ronit</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Gerstoft</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Nielsen</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Mohey</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Wiese</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Kvinesdal</surname><given-names>B</given-names></name>; <name name-style="western"><surname>Obel</surname><given-names>N</given-names></name>; <name name-style="western"><surname>Ahlstr&#246;hm</surname><given-names>MG</given-names></name><article-title>Non-AIDS Comorbid Conditions in Persons Living with Human Immunodeficiency Virus (HIV) Compared With Uninfected Individuals 10 Years Before HIV Diagnosis</article-title>. <source>Clin. Infect. Dis</source><year>2018</year>, <volume>67</volume>, <fpage>1291</fpage>&#8211;<lpage>1293</lpage>. [CrossRef]<pub-id pub-id-type="pmid">29672667</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciy325</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="webpage"><source>Facts and Figures</source>. Available online: <comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.medstarhealth.org/mhs/about-medstar/facts-and-figures/" ext-link-type="uri">https://www.medstarhealth.org/mhs/about-medstar/facts-and-figures/</ext-link></comment> (<date-in-citation>accessed on 12 July 2021</date-in-citation>).</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>. <article-title>Monitoring selected national HIV prevention and care objectives by using HIV surveillance data&#8212;United States and 6 dependent areas, 2018</article-title>. <source>HIV Surveill. Suppl. Rep</source><year>2020</year>, <volume>25</volume>. Available online: <comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-25-2.pdf" ext-link-type="uri">https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-25-2.pdf</ext-link></comment> (<date-in-citation>accessed on 12 July 2021</date-in-citation>).</mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Navickas</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Petric</surname><given-names>V-K</given-names></name>; <name name-style="western"><surname>Feigl</surname><given-names>AB</given-names></name>; <name name-style="western"><surname>Seychell</surname><given-names>M</given-names></name><article-title>Multimorbidity: What do we know? What should we do?</article-title><source>J. Comorb</source><year>2016</year>, <volume>6</volume>, <fpage>4</fpage>&#8211;<lpage>11</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">29090166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15256/joc.2016.6.72</pub-id><pub-id pub-id-type="pmcid">PMC5556462</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Burns</surname><given-names>EM</given-names></name>; <name name-style="western"><surname>Rigby</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Mamidanna</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Bottle</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Aylin</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Ziprin</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Faiz</surname><given-names>OD</given-names></name><article-title>Systematic review of discharge coding accuracy</article-title>. <source>J. Public Health</source><year>2012</year>, <volume>34</volume>, <fpage>138</fpage>&#8211;<lpage>148</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pubmed/fdr054</pub-id><pub-id pub-id-type="pmcid">PMC3285117</pub-id><pub-id pub-id-type="pmid">21795302</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="book"><name name-style="western"><surname>Peck</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Olsen</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Devore</surname><given-names>JL</given-names></name><source>Introduction to Statistics and Data Analysis</source>; <publisher-name>Cengage Learning</publisher-name>: <publisher-loc>Boston, MA, USA</publisher-loc>, <year>2015</year>.</mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Schriger</surname><given-names>DL</given-names></name><article-title>Book and media review</article-title>. <source>Ann. Emerg. Med</source><year>2008</year>, <volume>52</volume>, <fpage>480</fpage>. [CrossRef]</mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bilaloglu</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Aphinyanaphongs</surname><given-names>Y</given-names></name>; <name name-style="western"><surname>Jones</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Iturrate</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Hochman</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Berger</surname><given-names>JS</given-names></name><article-title>Thrombosis in Hospitalized Patients with COVID-19 in a New York City Health System</article-title>. <source>JAMA</source><year>2020</year>, <volume>324</volume>, <fpage>799</fpage>&#8211;<lpage>801</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32702090</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2020.13372</pub-id><pub-id pub-id-type="pmcid">PMC7372509</pub-id></mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Feng</surname><given-names>X</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Jiang</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Mei</surname><given-names>H</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>H</given-names></name>; <name name-style="western"><surname>Xia</surname><given-names>X</given-names></name>; <name name-style="western"><surname>Kong</surname><given-names>S</given-names></name>; <etal/><article-title>Deep Vein Thrombosis in Hospitalized Patients with COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome</article-title>. <source>Circulation</source><year>2020</year>, <volume>142</volume>, <fpage>114</fpage>&#8211;<lpage>128</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32421381</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.120.046702</pub-id></mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Naicker</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Rahmanian</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Kopp</surname><given-names>JB</given-names></name><article-title>HIV and chronic kidney disease</article-title>. <source>Clin. Nephrol</source><year>2015</year>, <volume>83</volume>, <fpage>32</fpage>&#8211;<lpage>38</lpage>. [CrossRef]<pub-id pub-id-type="pmid">25725239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5414/CNP83S032</pub-id><pub-id pub-id-type="pmcid">PMC4536633</pub-id></mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>So-Armah</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Benjamin</surname><given-names>LA</given-names></name>; <name name-style="western"><surname>Bloomfield</surname><given-names>GS</given-names></name>; <name name-style="western"><surname>Feinstein</surname><given-names>MJ</given-names></name>; <name name-style="western"><surname>Hsue</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Njuguna</surname><given-names>B</given-names></name>; <name name-style="western"><surname>Freiberg</surname><given-names>MS</given-names></name><article-title>HIV and cardiovascular disease</article-title>. <source>Lancet HIV</source><year>2020</year>, <volume>7</volume>, <fpage>e279</fpage>&#8211;<lpage>e293</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32243826</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2352-3018(20)30036-9</pub-id><pub-id pub-id-type="pmcid">PMC9346572</pub-id></mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Losina</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Hyle</surname><given-names>EP</given-names></name>; <name name-style="western"><surname>Borre</surname><given-names>ED</given-names></name>; <name name-style="western"><surname>Linas</surname><given-names>BP</given-names></name>; <name name-style="western"><surname>Sax</surname><given-names>PE</given-names></name>; <name name-style="western"><surname>Weinstein</surname><given-names>MC</given-names></name>; <name name-style="western"><surname>Rusu</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Ciaranello</surname><given-names>AL</given-names></name>; <name name-style="western"><surname>Walensky</surname><given-names>RP</given-names></name>; <name name-style="western"><surname>Freedberg</surname><given-names>KA</given-names></name><article-title>Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States</article-title>. <source>Clin. Infect. Dis</source><year>2017</year>, <volume>65</volume>, <fpage>1266</fpage>&#8211;<lpage>1271</lpage>. [CrossRef]<pub-id pub-id-type="pmid">28605504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/cix547</pub-id><pub-id pub-id-type="pmcid">PMC5850036</pub-id></mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bibas</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Biava</surname><given-names>G</given-names></name>; <name name-style="western"><surname>Antinori</surname><given-names>A</given-names></name><article-title>HIV-Associated Venous Thromboembolism</article-title>. <source>Mediterr. J. Hematol. Infect. Dis</source><year>2011</year>, <volume>3</volume>, e2011030. [CrossRef] [PubMed]<pub-id pub-id-type="doi" assigning-authority="pmc">10.4084/MJHID.2011.030</pub-id><pub-id pub-id-type="pmcid">PMC3152452</pub-id><pub-id pub-id-type="pmid">21869916</pub-id></mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jamal</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Bangash</surname><given-names>HI</given-names></name>; <name name-style="western"><surname>Habiba</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Lei</surname><given-names>Y</given-names></name>; <name name-style="western"><surname>Xie</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Wei</surname><given-names>Z</given-names></name>; <name name-style="western"><surname>Hong</surname><given-names>Z</given-names></name>; <name name-style="western"><surname>Shao</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></name><article-title>Immune dysregulation and system pathology in COVID-19</article-title>. <source>Virulence</source><year>2021</year>, <volume>12</volume>, <fpage>918</fpage>&#8211;<lpage>936</lpage>. [CrossRef]<pub-id pub-id-type="pmid">33757410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/21505594.2021.1898790</pub-id><pub-id pub-id-type="pmcid">PMC7993139</pub-id></mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Braunstein</surname><given-names>SL</given-names></name>; <name name-style="western"><surname>Lazar</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Wahnich</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Daskalakis</surname><given-names>DC</given-names></name>; <name name-style="western"><surname>Blackstock</surname><given-names>OJ</given-names></name><article-title>COVID-19 Infection Among People with HIV in New York City: A Population-Level Analysis of Matched Surveillance Data</article-title>. <source>SSRN Electron. J</source><year>2020</year>. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciaa1793</pub-id><pub-id pub-id-type="pmcid">PMC7799250</pub-id><pub-id pub-id-type="pmid">33252620</pub-id></mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yendewa</surname><given-names>GA</given-names></name>; <name name-style="western"><surname>Perez</surname><given-names>JA</given-names></name>; <name name-style="western"><surname>Schlick</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Tribout</surname><given-names>H</given-names></name>; <name name-style="western"><surname>McComsey</surname><given-names>GA</given-names></name><article-title>Clinical Features and Outcomes of Coronavirus Disease 2019 Among People with Human Immunodeficiency Virus in the United States: A Multicenter Study from a Large Global Health Research Network (TriNetX)</article-title>. <source>Open Forum Infect. Dis</source><year>2021</year>, <volume>8</volume>, ofab272. [CrossRef] [PubMed]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ofid/ofab272</pub-id><pub-id pub-id-type="pmcid">PMC8244788</pub-id><pub-id pub-id-type="pmid">34435074</pub-id></mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Hadi</surname><given-names>YB</given-names></name>; <name name-style="western"><surname>Naqvi SF</surname><given-names>Z</given-names></name>; <name name-style="western"><surname>Kupec</surname><given-names>JT</given-names></name>; <name name-style="western"><surname>Sarwari</surname><given-names>AR</given-names></name><article-title>Characteristics and outcomes of COVID-19 in patients with HIV: A multicentre research network study</article-title>. <source>AIDS</source><year>2020</year>, <volume>34</volume>, <fpage>F3</fpage>&#8211;<lpage>F8</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">32796217</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000002666</pub-id><pub-id pub-id-type="pmcid">PMC8407436</pub-id></mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Del Amo</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Polo</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Moreno</surname><given-names>S</given-names></name>; <name name-style="western"><surname>D&#237;az</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Mart&#237;nez</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Arribas</surname><given-names>JR</given-names></name>; <name name-style="western"><surname>Jarr&#237;n</surname><given-names>I</given-names></name>; <name name-style="western"><surname>Hern&#225;n</surname><given-names>MA</given-names></name>; <article-title>The Spanish HIV/COVID-19 Collaboration. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study</article-title>. <source>Ann. Intern. Med</source><year>2020</year>, <volume>173</volume>, <fpage>536</fpage>&#8211;<lpage>541</lpage>. [CrossRef]<pub-id pub-id-type="pmid">32589451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M20-3689</pub-id><pub-id pub-id-type="pmcid">PMC7394316</pub-id></mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Jassat</surname><given-names>W</given-names></name>; <name name-style="western"><surname>Cohen</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Masha</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Goldstein</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Kufa-Chakezha</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Savulescu</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Walaza</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Bam</surname><given-names>J-L</given-names></name>; <name name-style="western"><surname>Davies</surname><given-names>M-A</given-names></name>; <name name-style="western"><surname>Prozesky</surname><given-names>HW</given-names></name>; <etal/><article-title>A national cohort study of COVID-19 in-Hospital Mortality in South Africa: The Intersection of Communicable and Non-Communicable Chronic Diseases in a High HIV Prevalence Setting</article-title>. <source>medRxiv</source><year>2020</year>. [CrossRef]</mixed-citation></ref><ref id="R56"><label>56.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Rosenthal</surname><given-names>EM</given-names></name>; <name name-style="western"><surname>Rosenberg</surname><given-names>ES</given-names></name>; <name name-style="western"><surname>Patterson</surname><given-names>W</given-names></name>; <name name-style="western"><surname>Ferguson</surname><given-names>WP</given-names></name>; <name name-style="western"><surname>Gonzalez</surname><given-names>C</given-names></name>; <name name-style="western"><surname>DeHovitz</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Udo</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Rajulu</surname><given-names>DT</given-names></name>; <name name-style="western"><surname>Hart-Malloy</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Tesoriero</surname><given-names>J</given-names></name><article-title>Factors associated with SARS-CoV-2-related hospital outcomes among and between persons living with and without diagnosed HIV infection in New York State</article-title>. <source>PLoS ONE</source><year>2022</year>, <volume>17</volume>, e0268978. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0268978</pub-id><pub-id pub-id-type="pmcid">PMC9132290</pub-id><pub-id pub-id-type="pmid">35613145</pub-id></mixed-citation></ref><ref id="R57"><label>57.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ioannou</surname><given-names>GN</given-names></name>; <name name-style="western"><surname>Locke</surname><given-names>E</given-names></name>; <name name-style="western"><surname>Green</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Berry</surname><given-names>K</given-names></name>; <name name-style="western"><surname>O&#8217;Hare</surname><given-names>AM</given-names></name>; <name name-style="western"><surname>Shah</surname><given-names>JA</given-names></name>; <name name-style="western"><surname>Crothers</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Eastment</surname><given-names>MC</given-names></name>; <name name-style="western"><surname>Dominitz</surname><given-names>JA</given-names></name>; <name name-style="western"><surname>Fan</surname><given-names>VS</given-names></name><article-title>Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans with SARS-CoV-2 Infection</article-title>. <source>JAMA Netw. Open</source><year>2020</year>, <volume>3</volume>, e2022310. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2020.22310</pub-id><pub-id pub-id-type="pmcid">PMC7512055</pub-id><pub-id pub-id-type="pmid">32965502</pub-id></mixed-citation></ref><ref id="R58"><label>58.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Panagiotou</surname><given-names>OA</given-names></name>; <name name-style="western"><surname>Kosar</surname><given-names>CM</given-names></name>; <name name-style="western"><surname>White</surname><given-names>EM</given-names></name>; <name name-style="western"><surname>Bantis</surname><given-names>LE</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>; <name name-style="western"><surname>Santostefano</surname><given-names>CM</given-names></name>; <name name-style="western"><surname>Feifer</surname><given-names>RA</given-names></name>; <name name-style="western"><surname>Blackman</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Rudolph</surname><given-names>JL</given-names></name>; <name name-style="western"><surname>Gravenstein</surname><given-names>S</given-names></name>; <etal/><article-title>Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents with COVID-19</article-title>. <source>JAMA Intern. Med</source><year>2021</year>, <volume>181</volume>, <fpage>439</fpage>&#8211;<lpage>448</lpage>. [CrossRef]<pub-id pub-id-type="pmid">33394006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2020.7968</pub-id><pub-id pub-id-type="pmcid">PMC7783593</pub-id></mixed-citation></ref><ref id="R59"><label>59.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Booth</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Reed</surname><given-names>AB</given-names></name>; <name name-style="western"><surname>Ponzo</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Yassaee</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Aral</surname><given-names>M</given-names></name>; <name name-style="western"><surname>Plans</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Labrique</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Mohan</surname><given-names>D</given-names></name><article-title>Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis</article-title>. <source>PLoS ONE</source><year>2021</year>, <volume>16</volume>, e0247461. [CrossRef] [PubMed]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0247461</pub-id><pub-id pub-id-type="pmcid">PMC7932512</pub-id><pub-id pub-id-type="pmid">33661992</pub-id></mixed-citation></ref><ref id="R60"><label>60.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Patel</surname><given-names>RC</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Guo</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Zheng</surname><given-names>Q</given-names></name>; <name name-style="western"><surname>Olex</surname><given-names>AL</given-names></name>; <name name-style="western"><surname>Olatosi</surname><given-names>B</given-names></name>; <name name-style="western"><surname>Weissman</surname><given-names>SB</given-names></name>; <name name-style="western"><surname>Islam</surname><given-names>JY</given-names></name>; <etal/><article-title>Associations between HIV infection and clinical spectrum of COVID-19: A population level analysis based on US National COVID Cohort Collaborative (N3C) data</article-title>. <source>Lancet HIV</source><year>2021</year>, <volume>8</volume>, <fpage>e690</fpage>&#8211;<lpage>e700</lpage>. [CrossRef]<pub-id pub-id-type="pmid">34655550</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2352-3018(21)00239-3</pub-id><pub-id pub-id-type="pmcid">PMC8514200</pub-id></mixed-citation></ref><ref id="R61"><label>61.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Brown</surname><given-names>LB</given-names></name>; <name name-style="western"><surname>Spinelli</surname><given-names>MA</given-names></name>; <name name-style="western"><surname>Gandhi</surname><given-names>M</given-names></name><article-title>The interplay between HIV and COVID-19: Summary of the data and responses to date</article-title>. <source>Curr. Opin. HIV AIDS</source><year>2021</year>, <volume>16</volume>, <fpage>63</fpage>. [CrossRef]<pub-id pub-id-type="pmid">33186229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/COH.0000000000000659</pub-id><pub-id pub-id-type="pmcid">PMC7735216</pub-id></mixed-citation></ref><ref id="R62"><label>62.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Nomah</surname><given-names>DK</given-names></name>; <name name-style="western"><surname>Reyes-Urue&#241;a</surname><given-names>J</given-names></name>; <name name-style="western"><surname>D&#237;az</surname><given-names>Y</given-names></name>; <name name-style="western"><surname>Moreno</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Aceiton</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Bruguera</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Vivanco-Hidalgo</surname><given-names>RM</given-names></name>; <name name-style="western"><surname>Llibre</surname><given-names>JM</given-names></name>; <name name-style="western"><surname>Domingo</surname><given-names>P</given-names></name>; <name name-style="western"><surname>Falc&#243;</surname><given-names>V</given-names></name>; <etal/><article-title>Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: A retrospective cohort study</article-title>. <source>Lancet HIV</source><year>2021</year>, <volume>8</volume>, <fpage>e701</fpage>&#8211;<lpage>e710</lpage>. [CrossRef]<pub-id pub-id-type="pmid">34655549</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2352-3018(21)00240-X</pub-id><pub-id pub-id-type="pmcid">PMC8514194</pub-id></mixed-citation></ref><ref id="R63"><label>63.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Meyerowitz</surname><given-names>EA</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>AY</given-names></name>; <name name-style="western"><surname>Ard</surname><given-names>KL</given-names></name>; <name name-style="western"><surname>Basgoz</surname><given-names>N</given-names></name>; <name name-style="western"><surname>Chu</surname><given-names>JT</given-names></name>; <name name-style="western"><surname>Hurtado</surname><given-names>RM</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>CK</given-names></name>; <name name-style="western"><surname>He</surname><given-names>W</given-names></name>; <name name-style="western"><surname>Minukas</surname><given-names>T</given-names></name>; <name name-style="western"><surname>Nelson</surname><given-names>S</given-names></name>; <etal/><article-title>Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV</article-title>. <source>AIDS</source><year>2020</year>, <volume>34</volume>, <fpage>1781</fpage>&#8211;<lpage>1787</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="pmid">32604138</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000002607</pub-id><pub-id pub-id-type="pmcid">PMC7499878</pub-id></mixed-citation></ref><ref id="R64"><label>64.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Bhanja</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>D</given-names></name>; <name name-style="western"><surname>Gordon</surname><given-names>SH</given-names></name>; <name name-style="western"><surname>Allen</surname><given-names>H</given-names></name>; <name name-style="western"><surname>Sommers</surname><given-names>BD</given-names></name><article-title>Comparison of Income Eligibility for Medicaid vs. Marketplace Coverage for Insurance Enrollment Among Low-Income US Adults</article-title>. <source>JAMA Health Forum</source><year>2021</year>, <volume>2</volume>, e210771. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamahealthforum.2021.0771</pub-id><pub-id pub-id-type="pmcid">PMC8796906</pub-id><pub-id pub-id-type="pmid">35977174</pub-id></mixed-citation></ref><ref id="R65"><label>65.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shafer</surname><given-names>PR</given-names></name>; <name name-style="western"><surname>Anderson</surname><given-names>DM</given-names></name>; <name name-style="western"><surname>Whitaker</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Wong</surname><given-names>CA</given-names></name>; <name name-style="western"><surname>Wright</surname><given-names>B</given-names></name><article-title>Association of Unemployment with Medicaid Enrollment By Social Vulnerability In North Carolina During COVID-19</article-title>. <source>Health Aff</source>. <year>2021</year>, <volume>40</volume>, <fpage>1491</fpage>&#8211;<lpage>1500</lpage>. [CrossRef] [PubMed]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1377/hlthaff.2021.00377</pub-id><pub-id pub-id-type="pmid">34495714</pub-id></mixed-citation></ref><ref id="R66"><label>66.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Ingraham</surname><given-names>NE</given-names></name>; <name name-style="western"><surname>Purcell</surname><given-names>LN</given-names></name>; <name name-style="western"><surname>Karam</surname><given-names>BS</given-names></name>; <name name-style="western"><surname>Dudley</surname><given-names>RA</given-names></name>; <name name-style="western"><surname>Usher</surname><given-names>MG</given-names></name>; <name name-style="western"><surname>Warlick</surname><given-names>CA</given-names></name>; <name name-style="western"><surname>Allen</surname><given-names>ML</given-names></name>; <name name-style="western"><surname>Melton</surname><given-names>GB</given-names></name>; <name name-style="western"><surname>Charles</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Tignanelli</surname><given-names>CJ</given-names></name><article-title>Racial and Ethnic Disparities in Hospital Admissions from COVID-19: Determining the Impact of Neighborhood Deprivation and Primary Language</article-title>. <source>J. Gen. Intern. Med</source><year>2021</year>, <volume>36</volume>, <fpage>3462</fpage>&#8211;<lpage>3470</lpage>. [CrossRef]<pub-id pub-id-type="pmid">34003427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11606-021-06790-w</pub-id><pub-id pub-id-type="pmcid">PMC8130213</pub-id></mixed-citation></ref><ref id="R67"><label>67.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Dalsania</surname><given-names>AK</given-names></name>; <name name-style="western"><surname>Fastiggi</surname><given-names>MJ</given-names></name>; <name name-style="western"><surname>Kahlam</surname><given-names>A</given-names></name>; <name name-style="western"><surname>Shah</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Patel</surname><given-names>K</given-names></name>; <name name-style="western"><surname>Shiau</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Rokicki</surname><given-names>S</given-names></name>; <name name-style="western"><surname>DallaPiazza</surname><given-names>M</given-names></name><article-title>The Relationship Between Social Determinants of Health and Racial Disparities in COVID-19 Mortality</article-title>. <source>J. Racial Ethn. Health Disparities</source><year>2021</year>, <volume>9</volume>, <fpage>288</fpage>&#8211;<lpage>295</lpage>. [CrossRef]<pub-id pub-id-type="pmid">33403652</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40615-020-00952-y</pub-id><pub-id pub-id-type="pmcid">PMC7785288</pub-id></mixed-citation></ref><ref id="R68"><label>68.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Liebovitz</surname><given-names>DM</given-names></name>; <name name-style="western"><surname>Fahrenbach</surname><given-names>J</given-names></name><article-title>COUNTERPOINT: Is ICD-10 Diagnosis Coding Important in the Era of Big Data? No</article-title>. <source>Chest</source><year>2018</year>, <volume>153</volume>, <fpage>1095</fpage>&#8211;<lpage>1098</lpage>. [CrossRef]<pub-id pub-id-type="pmid">29476710</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2018.01.034</pub-id></mixed-citation></ref><ref id="R69"><label>69.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Weiner</surname><given-names>MG</given-names></name><article-title>POINT: Is ICD-10 Diagnosis Coding Important in the Era of Big Data? Yes</article-title>. <source>Chest</source><year>2018</year>, <volume>153</volume>, <fpage>1093</fpage>&#8211;<lpage>1095</lpage>. [CrossRef]<pub-id pub-id-type="pmid">29410203</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.chest.2018.01.025</pub-id></mixed-citation></ref><ref id="R70"><label>70.</label><mixed-citation publication-type="webpage"><source>ICD-ICD-10-CM-International Classification of Diseases, (ICD-10-CM/PCS) Transition</source>. <year>2019</year>. Available online: <comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/nchs/icd/icd10cm_pcs_background.htm" ext-link-type="uri">https://www.cdc.gov/nchs/icd/icd10cm_pcs_background.htm</ext-link></comment> (<date-in-citation>accessed on 14 July 2021</date-in-citation>).</mixed-citation></ref><ref id="R71"><label>71.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Wiley</surname><given-names>Z</given-names></name>; <name name-style="western"><surname>Kubes</surname><given-names>JN</given-names></name>; <name name-style="western"><surname>Cobb</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Jacob</surname><given-names>JT</given-names></name>; <name name-style="western"><surname>Franks</surname><given-names>N</given-names></name>; <name name-style="western"><surname>Plantinga</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Lea</surname><given-names>J</given-names></name><article-title>Age, Comorbid Conditions, and Racial Disparities in COVID-19 Outcomes</article-title>. <source>J. Racial Ethn. Health Disparities</source><year>2022</year>, <volume>9</volume>, <fpage>117</fpage>&#8211;<lpage>123</lpage>. [CrossRef]<pub-id pub-id-type="pmid">33415702</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40615-020-00934-0</pub-id><pub-id pub-id-type="pmcid">PMC7790329</pub-id></mixed-citation></ref><ref id="R72"><label>72.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Fu</surname><given-names>J</given-names></name>; <name name-style="western"><surname>Reid</surname><given-names>SA</given-names></name>; <name name-style="western"><surname>French</surname><given-names>B</given-names></name>; <name name-style="western"><surname>Hennessy</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Hwang</surname><given-names>C</given-names></name>; <name name-style="western"><surname>Gatson</surname><given-names>NT</given-names></name>; <name name-style="western"><surname>Duma</surname><given-names>N</given-names></name>; <name name-style="western"><surname>Mishra</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Nguyen</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Hawley</surname><given-names>JE</given-names></name>; <etal/><article-title>Racial Disparities in COVID-19 Outcomes Among Black and White Patients with Cancer</article-title>. <source>JAMA Netw. Open</source><year>2022</year>, <volume>5</volume>, e224304. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2022.4304</pub-id><pub-id pub-id-type="pmcid">PMC8961318</pub-id><pub-id pub-id-type="pmid">35344045</pub-id></mixed-citation></ref><ref id="R73"><label>73.</label><mixed-citation publication-type="journal"><name name-style="western"><surname>Shortreed</surname><given-names>SM</given-names></name>; <name name-style="western"><surname>Gray</surname><given-names>R</given-names></name>; <name name-style="western"><surname>Akosile</surname><given-names>MA</given-names></name>; <name name-style="western"><surname>Walker</surname><given-names>RL</given-names></name>; <name name-style="western"><surname>Fuller</surname><given-names>S</given-names></name>; <name name-style="western"><surname>Temposky</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Fortmann</surname><given-names>SP</given-names></name>; <name name-style="western"><surname>Albertson-Junkans</surname><given-names>L</given-names></name>; <name name-style="western"><surname>Floyd</surname><given-names>JS</given-names></name>; <name name-style="western"><surname>Bayliss</surname><given-names>EA</given-names></name>; <etal/><article-title>Increased COVID-19 Infection Risk Drives Racial and Ethnic Disparities in Severe COVID-19 Outcomes</article-title>. <source>J. Racial Ethn. Health Disparities</source><year>2022</year>. [CrossRef]<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40615-021-01205-2</pub-id><pub-id pub-id-type="pmcid">PMC8785693</pub-id><pub-id pub-id-type="pmid">35072944</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><title>PLWH seen in the MedStar healthcare system with and without SARS-CoV-2 Testing.</title><p id="P26">Flow chart of persons living with HIV seen in the MedStar Healthcare system. Abbreviations: HIV, Human Immunodeficiency Virus; PLWH, Persons Living with HIV; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-1871544-f0001.jpg"/></fig><fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><title>Persons with COVID-19 seen in the MedStar Healthcare system.</title><p id="P27">Figure of persons living with HIV and HIV-seronegative individuals seen in the MedStar Healthcare system with COVID-19. Abbreviations: HIV, Human Immunodeficiency Virus; COVID-19, coronavirus disease 2019.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihms-1871544-f0002.jpg"/></fig><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1.</label><caption><p id="P28">Comparison of age and sex matched PLWH and age/sex matched HIV-seronegative individuals with COVID-19.</p></caption><table frame="hsides" rules="rows"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="middle" rowspan="1" colspan="1">HIV-Seronegative (<italic toggle="yes">n</italic> = 1124)</th><th align="center" valign="middle" rowspan="1" colspan="1">HIV-Seropositive (<italic toggle="yes">n</italic> = 281)</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age mean years (SD)</td><td align="center" valign="middle" rowspan="1" colspan="1">51.2 (13.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">51.5 (12.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sex at Birth, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">708 (63)</td><td align="center" valign="middle" rowspan="1" colspan="1">177 (63)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">416 (37)</td><td align="center" valign="middle" rowspan="1" colspan="1">104 (37)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Race, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">African American/Black</td><td align="center" valign="middle" rowspan="1" colspan="1">388 (44)</td><td align="center" valign="middle" rowspan="1" colspan="1">237 (86)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">White</td><td align="center" valign="middle" rowspan="1" colspan="1">341 (39)</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (7)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Other</td><td align="center" valign="middle" rowspan="1" colspan="1">157 (18)</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (7)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ethnicity</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Non-Hispanic</td><td align="center" valign="middle" rowspan="1" colspan="1">813 (92)</td><td align="center" valign="middle" rowspan="1" colspan="1">258 (98)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hispanic</td><td align="center" valign="middle" rowspan="1" colspan="1">69 (8)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (2)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Insurance, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Private</td><td align="center" valign="middle" rowspan="1" colspan="1">818 (75)</td><td align="center" valign="middle" rowspan="1" colspan="1">161 (58)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Medicaid</td><td align="center" valign="middle" rowspan="1" colspan="1">79 (7)</td><td align="center" valign="middle" rowspan="1" colspan="1">67 (24)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Medicare</td><td align="center" valign="middle" rowspan="1" colspan="1">146 (13)</td><td align="center" valign="middle" rowspan="1" colspan="1">45 (16)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Non-Insured</td><td align="center" valign="middle" rowspan="1" colspan="1">46 (4)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (2)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Co-Morbid Conditions, <italic toggle="yes">n</italic> (%)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cardiovascular Disease</td><td align="center" valign="middle" rowspan="1" colspan="1">423 (38)</td><td align="center" valign="middle" rowspan="1" colspan="1">174 (62)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="middle" rowspan="1" colspan="1">403 (36)</td><td align="center" valign="middle" rowspan="1" colspan="1">165 (59)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Obesity</td><td align="center" valign="middle" rowspan="1" colspan="1">280 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">111 (40)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diabetes Mellitus</td><td align="center" valign="middle" rowspan="1" colspan="1">226 (20)</td><td align="center" valign="middle" rowspan="1" colspan="1">92 (33)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chronic Renal Disease</td><td align="center" valign="middle" rowspan="1" colspan="1">117 (10)</td><td align="center" valign="middle" rowspan="1" colspan="1">31 (11)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chronic Liver Disease</td><td align="center" valign="middle" rowspan="1" colspan="1">62 (6)</td><td align="center" valign="middle" rowspan="1" colspan="1">70 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Malignancy</td><td align="center" valign="middle" rowspan="1" colspan="1">19 (2)</td><td align="center" valign="middle" rowspan="1" colspan="1">28 (10)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Transplant</td><td align="center" valign="middle" rowspan="1" colspan="1">14 (1)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.062</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post-Infection Events, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Thrombotic</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (0.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.489</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Infections</td><td align="center" valign="middle" rowspan="1" colspan="1">14 (1)</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.206</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cardiovascular</td><td align="center" valign="middle" rowspan="1" colspan="1">22 (2)</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.253</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Acute Kidney Injury</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (1)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.120</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">INPATIENT</td><td align="center" valign="middle" rowspan="1" colspan="1">N = 269</td><td align="center" valign="middle" rowspan="1" colspan="1">N = 132</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Length of Stay, days (IQR)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (3, 11)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.5 (3, 11)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.889</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">ICU Median Length of Stay, days (IQR)</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (3, 15)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (1, 7.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.008</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Deceased, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">33 (13)</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (14)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.750</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Comorbid Conditions, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Diabetes Mellitus</td><td align="center" valign="middle" rowspan="1" colspan="1">110 (41)</td><td align="center" valign="middle" rowspan="1" colspan="1">50 (38)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.589</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cardiovascular Disease</td><td align="center" valign="middle" rowspan="1" colspan="1">67 (35)</td><td align="center" valign="middle" rowspan="1" colspan="1">35 (27)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.716</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chronic Renal Disease</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (11)</td><td align="center" valign="middle" rowspan="1" colspan="1">22 (17)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.154</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Chronic Liver Disease</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (4)</td><td align="center" valign="middle" rowspan="1" colspan="1">21 (16)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Malignancy</td><td align="center" valign="middle" rowspan="1" colspan="1">19 (7)</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (18)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post-Infection Events, <italic toggle="yes">n</italic> (%)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Thrombotic</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (0.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (0.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.551</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Infections</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (5)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (2)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.421</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cardiovascular</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (7)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.190</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Acute Kidney Injury</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (2)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">COVID Treatments <sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup>, <italic toggle="yes">n</italic> (%)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Remdesivir</td><td align="center" valign="middle" rowspan="1" colspan="1">39 (15)</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (14)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.880</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Dexamethasone</td><td align="center" valign="middle" rowspan="1" colspan="1">65 (24)</td><td align="center" valign="middle" rowspan="1" colspan="1">32 (24)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Azithromycin</td><td align="center" valign="middle" rowspan="1" colspan="1">120 (45)</td><td align="center" valign="middle" rowspan="1" colspan="1">58 (44)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.915</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hydroxychloroquine</td><td align="center" valign="middle" rowspan="1" colspan="1">49 (18)</td><td align="center" valign="middle" rowspan="1" colspan="1">22 (17)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.781</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Tocilizumab</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (7)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.504</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Supplemental Oxygen, <italic toggle="yes">n</italic> (%)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Room Air</td><td align="center" valign="middle" rowspan="1" colspan="1">38 (18)</td><td align="center" valign="middle" rowspan="1" colspan="1">27 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Nasal Cannula</td><td align="center" valign="middle" rowspan="1" colspan="1">82 (39)</td><td align="center" valign="middle" rowspan="1" colspan="1">33 (30)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.097</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Non-Rebreather/HFNC</td><td align="center" valign="middle" rowspan="1" colspan="1">29 (14)</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (23)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ventilator</td><td align="center" valign="middle" rowspan="1" colspan="1">53 (25)</td><td align="center" valign="middle" rowspan="1" colspan="1">21 (19)</td><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Laboratory Data (Admission <sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup>), (IQR)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median WBC (&#215;10<sup>3</sup> cells/&#956;L)</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (5.3, 9.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.80 (4.60, 9.20)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.060</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Absolute Lymphocyte count (&#215;10<sup>3</sup> cells/&#956;L)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.05 (0.80, 1.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.30 (0.80, 1.80)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.032</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mean Hemoglobin (gm/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.98 (12.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.23 (2.40)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.006</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mean Platelets (&#215;10<sup>3</sup> cells/&#956;L)</td><td align="center" valign="middle" rowspan="1" colspan="1">233 (95.52)</td><td align="center" valign="middle" rowspan="1" colspan="1">211.07 (91.78)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.036</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Creatinine (mg/dL)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.11 (0.83, 1.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.17 (0.89, 2.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.175</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mean eGFR (mL/min/1.73 m<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">50.07 (17.96)</td><td align="center" valign="middle" rowspan="1" colspan="1">46.10 (20.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.062</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median ALT (IU/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">37.00 (23, 58.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">33.00 (22, 49.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.224</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median CPK (units/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">148.50 (78.25, 326)</td><td align="center" valign="middle" rowspan="1" colspan="1">142 (75, 394)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.834</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Troponin (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02 (0.01, 0.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02 (0.01, 0.04)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.248</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Procalcitonin (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19 (0.10, 0.73)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.34 (0.10, 0.86)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.398</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Ferritin (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">592 (300, 1330.40)</td><td align="center" valign="middle" rowspan="1" colspan="1">565.15 (262.40, 1367.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.573</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Lactate Dehydrogenase (units/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">343.50 (264.50, 460.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">312.50 (238.5, 161.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.477</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median D-Dimer (mcg/mL FEU)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.66 (0.78, 3.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.44 (0.78, 3.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.902</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median C-Reactive Protein (mg/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">82.80 (35.05, 127.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">93.70 (53.50, 161.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.285</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Laboratory Data (Peak), (IQR)</td><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/><td align="left" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median WBC (&#215;10<sup>3</sup> cells/&#956;L)</td><td align="center" valign="middle" rowspan="1" colspan="1">10.20 (6.93, 14.97)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.90 (6, 12.70)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.010</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Platelets (&#215;10<sup>3</sup> cells/&#956;L)</td><td align="center" valign="middle" rowspan="1" colspan="1">307 (236.75, 417.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">263 (194, 371)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.008</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Procalcitonin (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22 (0.10, 2.30)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.39 (0.10, 1.70)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.498</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Ferritin (ng/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">896.1 (373.45, 1817.15)</td><td align="center" valign="middle" rowspan="1" colspan="1">707.40 (345, 1798.20)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.420</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Lactate Dehydrogenase (units/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">400.50 (284.50, 574)</td><td align="center" valign="middle" rowspan="1" colspan="1">355.5 (271, 576.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.615</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median D-Dimer (mcg/mL FEU)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.88 (1.09, 5.07)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.94 (0.93, 3.83)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.655</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mean C-Reactive Protein (mg/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">109 (47.40)</td><td align="center" valign="middle" rowspan="1" colspan="1">121.50 (61.70, 172.25)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.573</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Median Interleukin-6 (pg/mL)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.10 (5, 43.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (5, 18.60)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.412</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P29">Abbreviations: PLWH, persons living with HIV; N, number; SD, standard deviation; IQR, interquartile range; HFNC, high-flow nasal cannula; WBC, white blood cell count; mcL, microliters; gm, gram; dL, deciliter; eGFR, estimated glomerular filtration rate; mg, milligrams; mL, milliliter; min, minute; m, meter; IU, CPK, creatinine phosphokinase; international units, L, liter; ng, nanogram; mcg, micrograms; pg, picogramss.</p></fn><fn id="TFN2"><label>a</label><p id="P30">Other investigational treatments/treatments included vagepant (<italic toggle="yes">n</italic> = 0, HIV-seronegative; <italic toggle="yes">n</italic> = 1, HIV-seropositive) and extracorporeal membrane oxygenation (ECMO) (<italic toggle="yes">n</italic> = 0, HIV-seronegative; <italic toggle="yes">n</italic> = 1, HIV-seropositive).</p></fn><fn id="TFN3"><label>b</label><p id="P31">Laboratory data are from admission or first available.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2.</label><caption><p id="P32">Factors associated with hospitalization among persons living with HIV with COVID-19.</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="top" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="top" rowspan="1" colspan="1">OR</th><th align="center" valign="top" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th><th align="center" valign="top" rowspan="1" colspan="1">aOR <xref rid="TFN5" ref-type="table-fn">*</xref></th><th align="center" valign="top" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1">Age, years</td><td align="center" valign="top" rowspan="1" colspan="1">1.05 (1.03, 1.07)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.04 (1.01, 1.06)</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Sex at Birth</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Female (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="top" rowspan="1" colspan="1">1.12 (0.69, 1.83)</td><td align="center" valign="top" rowspan="1" colspan="1">0.646</td><td align="center" valign="top" rowspan="1" colspan="1">1.5 (0.87, 2.62)</td><td align="center" valign="top" rowspan="1" colspan="1">0.152</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Race</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">White (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">African American/Black</td><td align="center" valign="top" rowspan="1" colspan="1">0.6 (0.23, 1.5)</td><td align="center" valign="top" rowspan="1" colspan="1">0.278</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Other</td><td align="center" valign="top" rowspan="1" colspan="1">0.26 (0.06, 0.96)</td><td align="center" valign="top" rowspan="1" colspan="1">0.051</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Ethnicity</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Non-Hispanic (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Hispanic</td><td align="center" valign="top" rowspan="1" colspan="1">1.13 (0.21, 6.22)</td><td align="center" valign="top" rowspan="1" colspan="1">0.88</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">HIV Viral Load</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">&lt;200 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">&gt;200</td><td align="center" valign="top" rowspan="1" colspan="1">1 (1, 1)</td><td align="center" valign="top" rowspan="1" colspan="1">0.34</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">CD4 + T Lymphocyte</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">&gt;200 (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">&lt;200</td><td align="center" valign="top" rowspan="1" colspan="1">0.98 (0.91, 1.06)</td><td align="center" valign="top" rowspan="1" colspan="1">0.624</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Insurance</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Private (reference)</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="top" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Medicaid</td><td align="center" valign="top" rowspan="1" colspan="1">2.22 (1.25, 4)</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td align="center" valign="top" rowspan="1" colspan="1">2.61 (1.39, 4.97)</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Medicare</td><td align="center" valign="top" rowspan="1" colspan="1">2.4 (1.23, 4.77)</td><td align="center" valign="top" rowspan="1" colspan="1">0.011</td><td align="center" valign="top" rowspan="1" colspan="1">1.41 (0.67, 3.01)</td><td align="center" valign="top" rowspan="1" colspan="1">0.362</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Uninsured/Self-Pay</td><td align="center" valign="top" rowspan="1" colspan="1">0.8 (0.11, 4.22)</td><td align="center" valign="top" rowspan="1" colspan="1">0.798</td><td align="center" valign="top" rowspan="1" colspan="1">0.78 (0.09, 5.39)</td><td align="center" valign="top" rowspan="1" colspan="1">0.803</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Multimorbidity <xref rid="TFN6" ref-type="table-fn">**</xref></td><td align="center" valign="top" rowspan="1" colspan="1">3.74 (2.29, 6.21)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">2.98 (1.72, 5.23)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p id="P33">Abbreviations: SARS CoV-2, severe acute respiratory syndrome coronavirus 2; OR, odds ratio; aOR, adjusted odds ratio.</p></fn><fn id="TFN5"><label>*</label><p id="P34">Multivariable model adjusted for age, sex, insurance status, and multimorbidity,</p></fn><fn id="TFN6"><label>**</label><p id="P35">Multimorbidity = two or more comorbidities including cardiovascular disease, obesity, diabetes mellitus, chronic renal disease, or malignancy.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3.</label><caption><p id="P36">Factors associated with death/mechanical ventilation among hospitalized PLWH with COVID-19.</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="middle" rowspan="1" colspan="1">OR (CI 95%)</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th><th align="center" valign="middle" rowspan="1" colspan="1">aOR <xref rid="TFN8" ref-type="table-fn">*</xref></th><th align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr><tr><th colspan="5" align="center" valign="middle" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age, years</td><td align="center" valign="middle" rowspan="1" colspan="1">1.06 (1.03, 1.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.0001</td><td align="center" valign="middle" rowspan="1" colspan="1">1.06 (1.01, 1.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.013</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sex at Birth</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Female (reference)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">0.87 (0.4, 1.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.72</td><td align="center" valign="middle" rowspan="1" colspan="1">0.97 (0.42, 2.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.94</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Race</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">White (reference)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">African American/Black</td><td align="center" valign="middle" rowspan="1" colspan="1">2.34 (0.46, 42.92)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.416</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Other</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0, 2.44 &#215; 10<sup>15</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.987</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Ethnicity</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Non-Hispanic (reference)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Hispanic</td><td align="center" valign="middle" rowspan="1" colspan="1">1.95 (0.1, 12.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.55</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">HIV Viral Load</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&lt;200 (reference)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&gt;200</td><td align="center" valign="middle" rowspan="1" colspan="1">0.97 (0.84, 1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.592</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">CD4 + T Lymphocyte</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&gt;200 (reference)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&lt;200</td><td align="center" valign="middle" rowspan="1" colspan="1">1.05 (0.86, 1.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.64</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Insurance</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Private (reference)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Medicaid</td><td align="center" valign="middle" rowspan="1" colspan="1">2.97 (1.19, 7.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.019</td><td align="center" valign="middle" rowspan="1" colspan="1">3.6 (1.36, 9.74)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Medicare</td><td align="center" valign="middle" rowspan="1" colspan="1">2.78 (0.95, 7.73)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.051</td><td align="center" valign="middle" rowspan="1" colspan="1">1.33 (0.42, 3.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.614</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Uninsured/Self-Pay</td><td align="center" valign="middle" rowspan="1" colspan="1">7.55 (0.97, 43.98)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.029</td><td align="center" valign="middle" rowspan="1" colspan="1">12.09 (1.17, 1.26 &#215; 10<sup>2</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.027</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Multimorbidity <xref rid="TFN9" ref-type="table-fn">**</xref></td><td align="center" valign="middle" rowspan="1" colspan="1">6.55 (2.47, 22.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001</td><td align="center" valign="middle" rowspan="1" colspan="1">4.4 (1.55, 15.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.011</td></tr></tbody></table><table-wrap-foot><fn id="TFN7"><p id="P37">Abbreviations: OR, odds ratio; aOR, adjusted odds ratio.</p></fn><fn id="TFN8"><label>*</label><p id="P38">Multivariable model adjusted for age, sex, insurance status, and multimorbidity</p></fn><fn id="TFN9"><label>**</label><p id="P39">Multimorbidity = two or more comorbidities including cardiovascular disease, obesity, diabetes mellitus, chronic renal disease, or malignancy.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>